• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1012624-39
Medical Device Problem Code Device Damaged by Another Device (2915)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/12/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
G9: exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.Based on the information provided, the reported difficulties were due to procedural circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
It was reported that this was a peripheral percutaneous intervention treating the bilateral iliac arteries, moderately calcified lesions.Two omnilink elite stents were successfully placed.Imaging was performed with an unspecified catheter, when the catheter snagged the left iliac, 8x39mm omnilink elite stent.The stent was dragged down to the bifurcation at the common femoral with imaging catheter removal.The same imaging catheter was used to push the stent back to the desired implantation site.The stent was successfully re-expanded and was implanted at the desired location.There was no stent damage observed, however, as a precaution, another stent was successfully implanted, overlapping the 8x39mm omnilink elite stent.Reportedly, the procedure ended with good results noted.There was no adverse patient sequela and there was no clinically significant delay.No additional information was provided regarding this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE
Common Device Name
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9397610
Report Number2024168-2019-14024
Device Sequence Number14101797
Product Code NIO
UDI-Device Identifier08717648179303
UDI-Public08717648179303
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P110043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2021
Device Catalogue Number1012624-39
Device Lot Number7091941
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/12/2019
Initial Report FDA Received Date12/02/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
IMPLANTED OMNILINK ELITE STENT; IMPLANTED OMNILINK ELITE STENT
Outcome Attributed to Adverse Event Required Intervention;
Patient Age64 YR
Patient Weight91
-
-